SlideShare a Scribd company logo
Monitoring ART cycle
Aboubakr Elnashar
Benha university Hospital, Egypt
Aboubakr Elnashar
CONTENTS
I. METHODS OF MONITORING
II. OBJECTIVES OF MONOTORING
1. Prediction of ovarian response prior to COS
2. Monitor the effect of pituitary down-regulation.
3. Evaluate whether the dose of Gnt is adequate
or not
4. Prevention of OHSS.
5. Find the optimal time to give hCG.
6. Avoid cycle cancellation
III. CONCLUSION 3Aboubakr Elnashar
I. METHODS OF MONITORING
1. US:
 measurements of follicular growth
 endometrial thickness.
2. US and serum E2.
3. Power Doppler imaging
Perifollicular blood flow
4. 3D US.
 TVS is the most practical way {actual response of
ovaries and uterus}
Aboubakr Elnashar
II. OBJECTIVES OF MONOTORING
1. Prediction of ovarian response prior to COS
2. Monitor the effect of pituitary down-regulation.
3. Evaluate whether the dose of Gnt is adequate or
not
4. Prevention of OHSS.
5. Find the optimal time to give hCG.
6. Prevention of cycle cancellationAboubakr Elnashar
1.Prediction of ovarian response to Gnt
Aim:1. Identify poor responder
2. Identify risk of OHSS
Important:
To choose optimal starting dose of FSH.
Methods: Basal AFC, FSH, AMH
 AFC: superior to basal day 3 FSH. as well as BMI for
predicting the number of oocytes retrieved for lVF.
(Ng et al, 2005)
 ≤6: longer duration
higher dose of Gnt
less oocytes retrieved.
increased risk of cycle cancellation before OR
 ≥16: High responder
Aboubakr Elnashar
2. Monitoring the effect of pituitary down-
regulation.
Before starting follicular stimulation:
confirm down regulation (Criteria of suppression):
Hormonal assay
1. E2 < 50 ng/ml
2. LH < 5.0 IU/ml,
3. P4 < 1 ng/m ng/ml
Aboubakr Elnashar
 TVS:
1. No ovarian cysts
2. Number of small follicles (<8 mm) ≤ 4
3. Endometrial thickness <6 mm predicts down
regulation in 95% of cases
4. Ovarian artery resistance index: 0.9 have the
highest specificity and PPV
If not: stimulation is postponed and the assays
repeated after 2—4 further days of down-regulation.
Aboubakr Elnashar
3. Evaluate whether the dose of GnT is
adequate or not.
1. TVS:
A. 1st US
 D4 Stimulation
In PCO
 D 5 or 6 stimulation
In normal responder
Number: 6-8 each ovary
 With diameter: 11- 12 mmAboubakr Elnashar
B. Follow up
 Daily or Every other day depending on follicle size
 How:
Each follicle is measured in two perpendicular planes.
Then, the average of the four largest diameters is calculated.
 mean of two, three or four diameters, measured in one or two planes.
 Measure the internal diameter of the follicle in two
planes and the average diameter is then calculated.
 Follicles usually grow by 2-3 mm/d.
Aboubakr Elnashar
2. Combining US and E2
In normal responders:
seldom changes the timing of hCG
does not increase PR or the risk of OHSS
(Lass et al, 2003)
E2 D6
300 -600 pg/ml
 D6 E2 < 60 pg/ml: PR 7.8 %
If ok: continue the same dose.
If less than that: increase by one ampoule.
If greater than that: decrease the dose by ½ -1
amp Aboubakr Elnashar
Important in
1. If risk for OHSS.
2. Poor responder
E2 D5 stimulation:
<700 pmol/l: FSH dose is increased by 75-150 u
US on stimulation D9 or 10.
This is a simple way of early discovery that the
starting dose has been sufficient.
3. US monitoring shows adequate follicular growth
but inadequate endometrial growth
{low E production/follicle due to a low endogenous
LH level}: add rec LH
Aboubakr Elnashar
3. Color Doppler
A significant increased oocyte recovery from follicles with a
high peak systolic velocity as measured by pulsed Doppler
and gray-scale ultrasound (Naigund et al, 2007)
Oocytes from poorly vascularized follicles produced
morphologically poor embryos as compared to oocytes from
highly vascularized follicles.
Follicles with normal perifollicular blood flow contained
oocytes free of cytoplasmatic or chromosomal/ spindle
defects. (Van Blerkom et al, 2008)
high-grade follicular vascularity resulted in oocytes/embryos
that had an increased potential for becoming a full-term
pregnancy. (Chui et al, 2009)
Quantitative and qualitative assessment of peri-
follicular flow allow for a more accurate assessment of
follicular competence. Follicles that have >75% of
their surface perfused, or where PSV is >10 cm/s,
appear to contain an oocyte of satisfactory quality.
Aboubakr Elnashar
4. Combination of power Doppler angiography
(PDA) and 3D-US
for predicting and monitoring ovarian response in IVF-ET
(embryo transfer) cycles.
technique really improves the monitoring of the cycle is still
unclear.
technique is complicated and time consuming, making it less
practical for the daily monitoring of ART cycles.
Aboubakr Elnashar
4. Prevention of OHSS.
 Predicting of hyper-response
1. Previous history of OHSS
2. The presence of PCOS
3. Younger age
4. Lower BMI
5. High AMH
Aboubakr Elnashar
1. US :
a. PCO pattern of response to GnRH before GnT
b. Number of follicles >20
 Number of small & intermediate size (10-14 mm)
>15
 No risk when immature follicles are < 15.
{Number of the immature follicles is more important
than the number of mature follicles in predicting
OHSS.
c. Doppler:
low intraovarian vascular resistance
Combination of E2 & US: best chance for prediction
Aboubakr Elnashar
2. E2: High or rapid slope
<1000 pg/ml: No OHSS
>3000-4000 pg/ml: HCG should be withheld
<3500 pg/mL: No OHSS (Asch et al 2005)
3500-5999 pg/mL: 1.5%
6000 pg/mL: 38%
Cases with severe OHSS are seen with E2 <1500
pg/ml.
Small fraction of cases will be with excessive E2:
slope of rise of E2 is more accurate (considered if
the value is doubled).
Aboubakr Elnashar
Do not trigger ovulation with the intention of fresh
ET in women who have:
E2>3500 pg/ml or
>20 follicles on US
(NICE, 2013)
Aboubakr Elnashar
5. Find the optimal time to give hCG.
Ovulation when?
35-42 h after the onset of LH surge which triggers
resumption of meiosis inside the oocyte
HCG when?
3 or more follicles of size ≥17 mm
Endometrial thickness more than 8 mm
Aboubakr Elnashar
OR when?
When most of the follicles are large enough to
suggest the presence of mature oocytes.
Optimal oocyte recovery and fertilization rates can
be obtained from follicles between 14 and 24 mm in
diameter.
Oocyte recovery rates start to decrease after the
follicles exceed 24 mm in diameter.
No difference in the oocyte quality obtained from
follicles between 18 and 22 mm in diameter: more
convenient and predictable planning of oocyte
collection.
At least 35 h after HCG
Aboubakr Elnashar
US signs of impaired implantation at the time of
hCG administration
1. An endometrial thickness of <7 mm
2. Endometrial volume <2 cm3
3. Endometrial thickness >14 mm
4. Absence of multilayered endometrium
5. Uterine artery PI >3.0
6. Absence of subendometrial or reduction in the
endometrial vascularized area
Aboubakr Elnashar
If Endometrial thickness ≤7
1. Prolong ovulation induction until endometrial
thickness of >7 mm is achieved.
2. If pregnancy is not achieved, in a subsequent
cycle the ovulation induction regimen is changed
to allow for a better endometrial development.
Aboubakr Elnashar
6. Cycle cancellation
Define:
discontinuation of ovarian stimulation prematurely
without oocyte retrival.
Incidence
12% of all IVF cycles are cancelled before egg
collection.
Women's age Cancellation rate
Less than 35 7.7-10%
35-37 11.6-14.7%
38-40 14.6-19.5%
Over 40 19.1-24.6%
Aboubakr Elnashar
The main reasons
1.No or poor egg production (83%)
2.Patient’s personal reasons (10%)
3.Excessive response to ovarian stimulation and
risk of developing OHSS (5%)
4.Medical illness (1%).
(SART 2005 and HFEA 2006 Reports).
AMH:
all cases that was cancelled due to poor response
had AMH < 0.4 ng/ml. (La Marca et al., 2006)
all cases that was cancelled due to high risk of
OHSS had AMH >7 ng/ml.
Aboubakr Elnashar
Indications
1. Follicular growth is delayed:
ovarian stimulation over 10 days:
< 3 follicles > 16 mm & E2 < 600 pg/ml.
2.OHSS is suspected:
each ovary contains > 10 follicles < 16 mm &
E2 > 3500 pg/ml
Ovary size > 80 mm
3. Basal LH is elevated:
LH > 10 IU/l or a premature LH surge occurs
4. Elevated serum P4:
>1.5 ng/ml is detected prior to ovulation induction.
Aboubakr Elnashar
CONCLUSION
Two-dimensional ultrasound scanning of follicular
size is still the method of choice for monitoring IVF
cycles, irrespective of the protocol used for COH.
It is the most practical, and is still reliable enough
for monitoring ovarian stimulation with
gonadotropins.
Combining ultrasound monitoring of follicular size
with E2 is particularly valuable for monitoring poor
responders as well as those at risk for OHSS.
Aboubakr Elnashar
Thank youAboubakr Elnashar

More Related Content

PDF
Ovarian stimulation
PPTX
ultrasound biomicroscopy
PPSX
Intrauterine Insemination
PPTX
platelet rich plasma infertility
PPTX
Thin Endometrium
PPTX
EVALUATION OF inFERTILE WOMAN
PPTX
Focused approach to antenatal care - First trimester screening
PPTX
Pharmacotherapy in bronchial asthma and recent advances
Ovarian stimulation
ultrasound biomicroscopy
Intrauterine Insemination
platelet rich plasma infertility
Thin Endometrium
EVALUATION OF inFERTILE WOMAN
Focused approach to antenatal care - First trimester screening
Pharmacotherapy in bronchial asthma and recent advances

What's hot (20)

PPTX
Thin Endometrium & Infertility
PPTX
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
PPTX
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
PPSX
what is new in controlled ovarian stimulation?
PDF
Recent advances in stimulation protocols
PPTX
Monitoring of IVF Cycle - Dr Dhorepatil Bharati
PPTX
Ovulation Induction - Simplified - Dr Dhorepatil Bharati
PPT
GnRH antagonists
PPTX
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti Bh...
PPTX
AN IDEAL OVULATION INDUCTION REGIMEN
PDF
Treatment of decreased ovarian reserve
PPTX
Unexplained Infertility - By Dr Dhorepatil Bharati
PPS
OHSS: Prediction and prevention in non IVF cycles
PPTX
Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...
PDF
Triggering in Assisted Reproductive Technologies 2019
PDF
OVARIAN RESERVE
PPT
Ovulation induction in IUI
PPTX
Stimulation Protocols
PDF
ENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLES
PPTX
Optimizing IUI Outcome
Thin Endometrium & Infertility
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
what is new in controlled ovarian stimulation?
Recent advances in stimulation protocols
Monitoring of IVF Cycle - Dr Dhorepatil Bharati
Ovulation Induction - Simplified - Dr Dhorepatil Bharati
GnRH antagonists
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti Bh...
AN IDEAL OVULATION INDUCTION REGIMEN
Treatment of decreased ovarian reserve
Unexplained Infertility - By Dr Dhorepatil Bharati
OHSS: Prediction and prevention in non IVF cycles
Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...
Triggering in Assisted Reproductive Technologies 2019
OVARIAN RESERVE
Ovulation induction in IUI
Stimulation Protocols
ENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLES
Optimizing IUI Outcome
Ad

Similar to Monitoring ART cycle Aboubakr Elnashar (20)

PDF
Is ultrasound monitoring alone enough in ART cycle?
PDF
Gonadotrpin ovarian stimulation: Aboubakr elnashar
PDF
Patient preparation before IVF
PPT
Abnormal Uterine Bleeding1107 Holm
PDF
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
PDF
Emergency ultrasonography in 2nd 3rd timester
PDF
Infertility management 2019
PPTX
Intrapartum fetal monitering
PPT
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal
PDF
Abnormal uterine bleeding
PPT
Practical tips for monitoring of an iui cycle
PDF
Blood transfusion in ostetrics2019
PPTX
Gynaecological emergency
PDF
Ivf in pcos
PDF
ART PREGNANCY COMPLICATIONS Prof. Aboubakr Elnashar
PDF
ART PREGNANCY COMPLICATIONS
PDF
Management of adenxal mass during pregnancy
PPTX
Principle of fetal monitoring
PPTX
Foetal Monitoring
PDF
Management of infertility
Is ultrasound monitoring alone enough in ART cycle?
Gonadotrpin ovarian stimulation: Aboubakr elnashar
Patient preparation before IVF
Abnormal Uterine Bleeding1107 Holm
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
Emergency ultrasonography in 2nd 3rd timester
Infertility management 2019
Intrapartum fetal monitering
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal
Abnormal uterine bleeding
Practical tips for monitoring of an iui cycle
Blood transfusion in ostetrics2019
Gynaecological emergency
Ivf in pcos
ART PREGNANCY COMPLICATIONS Prof. Aboubakr Elnashar
ART PREGNANCY COMPLICATIONS
Management of adenxal mass during pregnancy
Principle of fetal monitoring
Foetal Monitoring
Management of infertility
Ad

More from Aboubakr Elnashar (20)

PDF
hepatitis B.pdf
PDF
hepatitis c2022.pdf
PDF
Adenomyosis associated infertility
PDF
Endometriosis associated infertility: ESHRE2022
PDF
Adenxal mass guidelines2020
PDF
Aesthetic gynecology controversy
PDF
Hormonal assay in clinical gyn
PDF
FIRST TRIMESTER ANC OF IVF
PDF
Unnecessary investigations in reproductive medicine
PDF
Infertility prevention
PDF
Individualisation of controlled ovarian stimulation
PDF
Female infertility
PDF
Maternal near miss
PDF
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
PDF
cesarean birth: procedural aspects: NICE2021
PDF
CAESAREAN SCAR DEFECT
PDF
Management of pregnancy of unknown location
PDF
Aerobic Vaginitis
PDF
COVID 19 infection and pregnancy RCOG2021
PDF
Imaging in pregnancy 2 in1
hepatitis B.pdf
hepatitis c2022.pdf
Adenomyosis associated infertility
Endometriosis associated infertility: ESHRE2022
Adenxal mass guidelines2020
Aesthetic gynecology controversy
Hormonal assay in clinical gyn
FIRST TRIMESTER ANC OF IVF
Unnecessary investigations in reproductive medicine
Infertility prevention
Individualisation of controlled ovarian stimulation
Female infertility
Maternal near miss
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
cesarean birth: procedural aspects: NICE2021
CAESAREAN SCAR DEFECT
Management of pregnancy of unknown location
Aerobic Vaginitis
COVID 19 infection and pregnancy RCOG2021
Imaging in pregnancy 2 in1

Recently uploaded (20)

PPTX
NEET PG 2025: Memory-Based Recall Questions Compiled by Dr. Shivankan Kakkar, MD
PDF
Khadir.pdf Acacia catechu drug Ayurvedic medicine
PPTX
Nirsevimab in India - Single-Dose Monoclonal Antibody to Combat RSV .pptx
PDF
Writing and Teaching as Personal Documentation of Continuing Professional Dev...
PPTX
SKIN Anatomy and physiology and associated diseases
PPTX
Slider: TOC sampling methods for cleaning validation
PPTX
Gastroschisis- Clinical Overview 18112311
DOCX
Pathology Paper I – II MBBS Main Exam (July 2025) | New CBME Scheme
PPTX
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
PPT
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
PDF
coagulation disorders in anaesthesia pdf
PDF
Medical Evidence in the Criminal Justice Delivery System in.pdf
PPTX
Thyroid Applied Anatomy, Pysiology, Development with MCQs.pptx
PPTX
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PPTX
Uterus anatomy embryology, and clinical aspects
PDF
Cervical Spondylosis - An Overview of Degenerative Cervical Spine Disease
PPTX
ACID BASE management, base deficit correction
PDF
Neuro ED Bet Sexologist in Patna Bihar India Dr. Sunil Dubey
PPTX
Neurotransmitter, Types of neurotransmitters,Neurotransmitter function, Neur...
NEET PG 2025: Memory-Based Recall Questions Compiled by Dr. Shivankan Kakkar, MD
Khadir.pdf Acacia catechu drug Ayurvedic medicine
Nirsevimab in India - Single-Dose Monoclonal Antibody to Combat RSV .pptx
Writing and Teaching as Personal Documentation of Continuing Professional Dev...
SKIN Anatomy and physiology and associated diseases
Slider: TOC sampling methods for cleaning validation
Gastroschisis- Clinical Overview 18112311
Pathology Paper I – II MBBS Main Exam (July 2025) | New CBME Scheme
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
coagulation disorders in anaesthesia pdf
Medical Evidence in the Criminal Justice Delivery System in.pdf
Thyroid Applied Anatomy, Pysiology, Development with MCQs.pptx
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
Uterus anatomy embryology, and clinical aspects
Cervical Spondylosis - An Overview of Degenerative Cervical Spine Disease
ACID BASE management, base deficit correction
Neuro ED Bet Sexologist in Patna Bihar India Dr. Sunil Dubey
Neurotransmitter, Types of neurotransmitters,Neurotransmitter function, Neur...

Monitoring ART cycle Aboubakr Elnashar

  • 1. Monitoring ART cycle Aboubakr Elnashar Benha university Hospital, Egypt Aboubakr Elnashar
  • 2. CONTENTS I. METHODS OF MONITORING II. OBJECTIVES OF MONOTORING 1. Prediction of ovarian response prior to COS 2. Monitor the effect of pituitary down-regulation. 3. Evaluate whether the dose of Gnt is adequate or not 4. Prevention of OHSS. 5. Find the optimal time to give hCG. 6. Avoid cycle cancellation III. CONCLUSION 3Aboubakr Elnashar
  • 3. I. METHODS OF MONITORING 1. US:  measurements of follicular growth  endometrial thickness. 2. US and serum E2. 3. Power Doppler imaging Perifollicular blood flow 4. 3D US.  TVS is the most practical way {actual response of ovaries and uterus} Aboubakr Elnashar
  • 4. II. OBJECTIVES OF MONOTORING 1. Prediction of ovarian response prior to COS 2. Monitor the effect of pituitary down-regulation. 3. Evaluate whether the dose of Gnt is adequate or not 4. Prevention of OHSS. 5. Find the optimal time to give hCG. 6. Prevention of cycle cancellationAboubakr Elnashar
  • 5. 1.Prediction of ovarian response to Gnt Aim:1. Identify poor responder 2. Identify risk of OHSS Important: To choose optimal starting dose of FSH. Methods: Basal AFC, FSH, AMH  AFC: superior to basal day 3 FSH. as well as BMI for predicting the number of oocytes retrieved for lVF. (Ng et al, 2005)  ≤6: longer duration higher dose of Gnt less oocytes retrieved. increased risk of cycle cancellation before OR  ≥16: High responder Aboubakr Elnashar
  • 6. 2. Monitoring the effect of pituitary down- regulation. Before starting follicular stimulation: confirm down regulation (Criteria of suppression): Hormonal assay 1. E2 < 50 ng/ml 2. LH < 5.0 IU/ml, 3. P4 < 1 ng/m ng/ml Aboubakr Elnashar
  • 7.  TVS: 1. No ovarian cysts 2. Number of small follicles (<8 mm) ≤ 4 3. Endometrial thickness <6 mm predicts down regulation in 95% of cases 4. Ovarian artery resistance index: 0.9 have the highest specificity and PPV If not: stimulation is postponed and the assays repeated after 2—4 further days of down-regulation. Aboubakr Elnashar
  • 8. 3. Evaluate whether the dose of GnT is adequate or not. 1. TVS: A. 1st US  D4 Stimulation In PCO  D 5 or 6 stimulation In normal responder Number: 6-8 each ovary  With diameter: 11- 12 mmAboubakr Elnashar
  • 9. B. Follow up  Daily or Every other day depending on follicle size  How: Each follicle is measured in two perpendicular planes. Then, the average of the four largest diameters is calculated.  mean of two, three or four diameters, measured in one or two planes.  Measure the internal diameter of the follicle in two planes and the average diameter is then calculated.  Follicles usually grow by 2-3 mm/d. Aboubakr Elnashar
  • 10. 2. Combining US and E2 In normal responders: seldom changes the timing of hCG does not increase PR or the risk of OHSS (Lass et al, 2003) E2 D6 300 -600 pg/ml  D6 E2 < 60 pg/ml: PR 7.8 % If ok: continue the same dose. If less than that: increase by one ampoule. If greater than that: decrease the dose by ½ -1 amp Aboubakr Elnashar
  • 11. Important in 1. If risk for OHSS. 2. Poor responder E2 D5 stimulation: <700 pmol/l: FSH dose is increased by 75-150 u US on stimulation D9 or 10. This is a simple way of early discovery that the starting dose has been sufficient. 3. US monitoring shows adequate follicular growth but inadequate endometrial growth {low E production/follicle due to a low endogenous LH level}: add rec LH Aboubakr Elnashar
  • 12. 3. Color Doppler A significant increased oocyte recovery from follicles with a high peak systolic velocity as measured by pulsed Doppler and gray-scale ultrasound (Naigund et al, 2007) Oocytes from poorly vascularized follicles produced morphologically poor embryos as compared to oocytes from highly vascularized follicles. Follicles with normal perifollicular blood flow contained oocytes free of cytoplasmatic or chromosomal/ spindle defects. (Van Blerkom et al, 2008) high-grade follicular vascularity resulted in oocytes/embryos that had an increased potential for becoming a full-term pregnancy. (Chui et al, 2009) Quantitative and qualitative assessment of peri- follicular flow allow for a more accurate assessment of follicular competence. Follicles that have >75% of their surface perfused, or where PSV is >10 cm/s, appear to contain an oocyte of satisfactory quality. Aboubakr Elnashar
  • 13. 4. Combination of power Doppler angiography (PDA) and 3D-US for predicting and monitoring ovarian response in IVF-ET (embryo transfer) cycles. technique really improves the monitoring of the cycle is still unclear. technique is complicated and time consuming, making it less practical for the daily monitoring of ART cycles. Aboubakr Elnashar
  • 14. 4. Prevention of OHSS.  Predicting of hyper-response 1. Previous history of OHSS 2. The presence of PCOS 3. Younger age 4. Lower BMI 5. High AMH Aboubakr Elnashar
  • 15. 1. US : a. PCO pattern of response to GnRH before GnT b. Number of follicles >20  Number of small & intermediate size (10-14 mm) >15  No risk when immature follicles are < 15. {Number of the immature follicles is more important than the number of mature follicles in predicting OHSS. c. Doppler: low intraovarian vascular resistance Combination of E2 & US: best chance for prediction Aboubakr Elnashar
  • 16. 2. E2: High or rapid slope <1000 pg/ml: No OHSS >3000-4000 pg/ml: HCG should be withheld <3500 pg/mL: No OHSS (Asch et al 2005) 3500-5999 pg/mL: 1.5% 6000 pg/mL: 38% Cases with severe OHSS are seen with E2 <1500 pg/ml. Small fraction of cases will be with excessive E2: slope of rise of E2 is more accurate (considered if the value is doubled). Aboubakr Elnashar
  • 17. Do not trigger ovulation with the intention of fresh ET in women who have: E2>3500 pg/ml or >20 follicles on US (NICE, 2013) Aboubakr Elnashar
  • 18. 5. Find the optimal time to give hCG. Ovulation when? 35-42 h after the onset of LH surge which triggers resumption of meiosis inside the oocyte HCG when? 3 or more follicles of size ≥17 mm Endometrial thickness more than 8 mm Aboubakr Elnashar
  • 19. OR when? When most of the follicles are large enough to suggest the presence of mature oocytes. Optimal oocyte recovery and fertilization rates can be obtained from follicles between 14 and 24 mm in diameter. Oocyte recovery rates start to decrease after the follicles exceed 24 mm in diameter. No difference in the oocyte quality obtained from follicles between 18 and 22 mm in diameter: more convenient and predictable planning of oocyte collection. At least 35 h after HCG Aboubakr Elnashar
  • 20. US signs of impaired implantation at the time of hCG administration 1. An endometrial thickness of <7 mm 2. Endometrial volume <2 cm3 3. Endometrial thickness >14 mm 4. Absence of multilayered endometrium 5. Uterine artery PI >3.0 6. Absence of subendometrial or reduction in the endometrial vascularized area Aboubakr Elnashar
  • 21. If Endometrial thickness ≤7 1. Prolong ovulation induction until endometrial thickness of >7 mm is achieved. 2. If pregnancy is not achieved, in a subsequent cycle the ovulation induction regimen is changed to allow for a better endometrial development. Aboubakr Elnashar
  • 22. 6. Cycle cancellation Define: discontinuation of ovarian stimulation prematurely without oocyte retrival. Incidence 12% of all IVF cycles are cancelled before egg collection. Women's age Cancellation rate Less than 35 7.7-10% 35-37 11.6-14.7% 38-40 14.6-19.5% Over 40 19.1-24.6% Aboubakr Elnashar
  • 23. The main reasons 1.No or poor egg production (83%) 2.Patient’s personal reasons (10%) 3.Excessive response to ovarian stimulation and risk of developing OHSS (5%) 4.Medical illness (1%). (SART 2005 and HFEA 2006 Reports). AMH: all cases that was cancelled due to poor response had AMH < 0.4 ng/ml. (La Marca et al., 2006) all cases that was cancelled due to high risk of OHSS had AMH >7 ng/ml. Aboubakr Elnashar
  • 24. Indications 1. Follicular growth is delayed: ovarian stimulation over 10 days: < 3 follicles > 16 mm & E2 < 600 pg/ml. 2.OHSS is suspected: each ovary contains > 10 follicles < 16 mm & E2 > 3500 pg/ml Ovary size > 80 mm 3. Basal LH is elevated: LH > 10 IU/l or a premature LH surge occurs 4. Elevated serum P4: >1.5 ng/ml is detected prior to ovulation induction. Aboubakr Elnashar
  • 25. CONCLUSION Two-dimensional ultrasound scanning of follicular size is still the method of choice for monitoring IVF cycles, irrespective of the protocol used for COH. It is the most practical, and is still reliable enough for monitoring ovarian stimulation with gonadotropins. Combining ultrasound monitoring of follicular size with E2 is particularly valuable for monitoring poor responders as well as those at risk for OHSS. Aboubakr Elnashar